Minimizing distrust, explaining process essential to increasing trial participation

admin
1 Min Read

Barbara Kienzle, a presenter at the 2024 Rheumatology Nurses Society annual conference, discussed the importance of explaining the clinical trial process to minimize barriers to research participation. Many patients are hesitant to participate due to lack of interest, time commitments, competing demands, and distrust. Kienzle emphasized the need for healthcare providers to tailor conversations about trials to each patient, provide easily understandable materials, and ensure patients understand the voluntary nature of participation. She also highlighted the importance of being familiar with the rules and regulations surrounding clinical trials and respecting patients’ autonomy to decline or stop participation at any time.

Source link

Share This Article
error: Content is protected !!